Skip to main content
SpringerLink
Log in

Perianal disease is associated with psychiatric co-morbidity in Crohn’s disease in remission

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Background and aim

Crohn’s disease is a life-long inflammatory disease which can impair quality of life, in particular in patients with psychiatric co-morbidities such as depression and anxiety. The aim of this prospective cohort study was to assess the prevalence of depression and anxiety and related risk factors in patients with quiescent Crohn’s disease.

Methods

A consecutive series of adult patients with confirmed diagnosis of Crohn’s disease, in clinical remission, were included and investigated during ambulatory visits using a standard questionnaire assessing demographic and clinical features of the disease. Within 1 month after the ambulatory visit, all patients were interviewed by phone to assess the presence of psychiatric disorders using standardized questionnaires. The questionnaire assessed the development of psychiatric disorders after the diagnosis of Crohn’s disease, the use of antidepressant or antianxiety therapy and current anxiety or depression by means of the Hospital Anxiety and Depression Scale.

Results

One hundred and ninety-five patients were included. Seventy-two (36.9 %) patients showed anxiety and/or depression symptoms, 46 (23.6 %) patients showed anxiety symptoms, 6 (3.1 %) patients showed depression symptoms and 20 (10.3 %) patients showed both symptoms. Forty-eight of these patients (58 %) were without any antidepressive or antianxiety treatment. Anxiety with or without depression was significantly correlated with female sex (p = 0.017), history of perianal disease (p = 0.003) and perianal surgery (p = 0.042).

Conclusion

Anxiety is a frequent, often untreated, condition in patient affected by Crohn’s disease in clinical remission. Female sex, history of perianal disease and perianal surgery are major risk factors for anxiety.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Sachar DB (2006) Recurrence rates in Crohn’s disease: predicting the future and predicting the past. Gut 55:1069–1070

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  2. Sachar DB (1990) The problem of postoperative recurrence of Crohn’s disease. Med Clin N Am 74:183–188

    PubMed  CAS  Google Scholar 

  3. Fazio VW, Marchetti F, Church M, Goldblum JR, Lavery C, Hull TL et al (1996) Effect of resection margins on the recurrence of Crohn’s disease in the small bowel. A randomized controlled trial. Ann Surg 224:563–571

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  4. Sampietro GM, Cristaldi M, Porretta T, Montecamozzo G, Danelli P, Taschieri AM (2000) Early perioperative results and surgical recurrence after strictureplasty and miniresection for complicated Crohn’s disease. Dig Surg 17:261–267

    Article  PubMed  CAS  Google Scholar 

  5. Cristaldi M, Sampietro GM, Danelli PG, Bollani S, Bianchi Porro G, Taschieri AM (2000) Long-term results and multivariate analysis of prognostic factors in 138 consecutive patients operated on for Crohn’s disease using “bowel-sparing” techniques. Am J Surg 179:266–270

    Article  PubMed  CAS  Google Scholar 

  6. Hellers G, Bergstrand O, Ewerth S, Holmstrom B (1980) Occurrence and outcome after primary treatment of anal fistulae in Crohn’s disease. Gut 21:525–527

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  7. Schwartz DA, Loftus EV Jr, Tremaine WJ, Panaccione R, Harmsen WS, Zinsmeister AR et al (2002) The natural history of fistulizing Crohn’s disease in Olmsted County, Minnesota. Gastroenterology 122:875–880

    Article  PubMed  Google Scholar 

  8. Ingle SB, Loftus EV Jr (2007) The natural history of perianal Crohn’s disease. Digest Liver Dis 39:963–969

    Article  CAS  Google Scholar 

  9. Graff LA, Walker JR, Bernstein CN (2009) Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflamm Bowel Dis 15:1105–1118

    Article  PubMed  Google Scholar 

  10. Graff LA, Walker JR, Lix L, Clara I, Rawsthorne P, Rogala L et al (2006) The relationship of inflammatory bowel disease type and activity to psychological functioning and quality of life. Clin Gastroenterol Hepatol 4:1491–1501

    Article  PubMed  Google Scholar 

  11. Nahon S, Lahmek P, Durance C, Olympie A, Lesgourgues B, Colombel JF et al (2012) Risk factors of anxiety and depression in inflammatory bowel disease. Inflamm Bowel Dis 18:2086–2091

    Article  PubMed  Google Scholar 

  12. Loftus EV Jr, Guerin A, Yu AP, Wu EQ, Yang M, Chao J et al (2011) Increased risks of developing anxiety and depression in young patients with Crohn’s disease. Am J Gastroenterol 106:1670–1677

    Article  PubMed  Google Scholar 

  13. Ananthakrishnan AN, Gainer VS, Cai T, Perez RG, Cheng SC, Savova G et al (2013) Similar risk of depression and anxiety following surgery or hospitalization for Crohn’s disease and ulcerative colitis. Am J Gastroenterol 108:594–601

    Article  PubMed  PubMed Central  Google Scholar 

  14. Best WR, Becktel JM, Singleton JW, Kern F Jr (1976) Development of a Crohn’s disease activity index: National Cooperative Crohn’s Disease Study. Gastroenterology 70:439–444

    PubMed  CAS  Google Scholar 

  15. Present DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, van Hogezand RA et al (1999) Infliximab for the treatment of fistulas in patients with Crohn’s disease. N Engl J Med 340:1398–1405

    Article  PubMed  CAS  Google Scholar 

  16. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370

    Article  PubMed  CAS  Google Scholar 

  17. Bjelland I, Dahl AA, Haug TT, Neckelmann D (2002) The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 52:69–77

    Article  PubMed  Google Scholar 

  18. Mittermaier C, Dejaco C, Waldhoer T, Oefferlbauer-Ernst A, Miehsler W, Beier M et al (2004) Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom Med 66:79–84

    Article  PubMed  Google Scholar 

  19. Goodhand JR, Wahed M, Mawdsley JE, Farmer AD, Aziz Q, Rampton DS (2012) Mood disorders in inflammatory bowel disease: relation to diagnosis, disease activity, perceived stress, and other factors. Inflamm Bowel Dis 18:2301–2309

    Article  PubMed  CAS  Google Scholar 

  20. Addolorato G, Capristo E, Stefanini GF, Gasbarrini G (1997) Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity, and nutritional status. Scand J Gastroenterol 32:1013–1021

    Article  PubMed  CAS  Google Scholar 

  21. Iglesias M, de Acosta Barreiro M, Vázquez I, Figueiras A, Nieto L, Lorenzo A, Domínguez-Muñoz JE (2009) Psychological impact of Crohn’s disease on patients in remission: anxiety and depression risks. Rev Esp Enferm Dig 101:249–257

    Article  PubMed  CAS  Google Scholar 

  22. Mikocka-Walus AA, Turnbull DA, Moulding NT, Wilson IG, Holtmann GJ, Andrews JM (2008) Does psychological status influence clinical outcomes in patients with inflammatory bowel diseases and other chronic gastroenterological diseases? An observational cohort prospective study. Biopsy Med 2:11

    Article  Google Scholar 

  23. Porcelli P, Leoci C, Guerra V (1996) A prospective study of the relationship between disease activity and psychological distress in patients with inflammatory bowel disease. Scand J Gastroenterol 31:792–796

    Article  PubMed  CAS  Google Scholar 

  24. Mardini HE, Kip KE, Wilson JW (2004) Crohn’s disease: a two-year prospective study of the association between psychological distress and disease activity. Dig Dis Sci 49:492–497

    Article  PubMed  Google Scholar 

  25. Persoons P, Vermeire S, Demyttenaere K, Fischler B, Vandenberghe J, Van Oudenhove L et al (2005) The impact of major depressive disorder on the short- and long-term outcome of Crohn’s disease treatment with infliximab. Aliment Pharmacol Ther 22:101–110

    Article  PubMed  CAS  Google Scholar 

  26. Bennebroek Evertsz’ F, Thijssens NA, Stokkers PC, Grootenhuis MA, Bockting CL, Nieuwkerk PT et al (2012) Do inflammatory bowel disease patients with anxiety and depressive symptoms receive the care they need? J Crohns Colitis 6:68–76

    Article  PubMed  Google Scholar 

  27. Ananthakrishnan AN, Gainer VS, Perez RG, Cai T, Cheng SC, Savova G et al (2013) Psychiatric co-morbidity is associated with increased risk of surgery in Crohn’s disease. Aliment Pharmacol Ther 37:445–454

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  28. Zhang CK, Hewett J, Hemming J, Grant T, Zhao H, Abraham C et al (2013) The influence of depression on quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis 19:1732–1739

    Article  PubMed  Google Scholar 

  29. Berrill JW, Green JT, Hood K, Campbell AK (2013) Symptoms of irritable bowel syndrome in patients with inflammatory bowel disease: examining the role of sub-clinical inflammation and the impact on clinical assessment of disease activity. Aliment Pharmacol Ther 38:44–51

    Article  PubMed  CAS  Google Scholar 

  30. Goodhand JR, Greig FI, Koodun Y, McDermott A, Wahed M, Langmead L et al (2012) Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case-matched observational study. Inflamm Bowel Dis 18:1232–1239

    Article  PubMed  CAS  Google Scholar 

  31. Mikocka-Walus A, Andrews JM (2013) Attitudes towards antidepressants among people living with inflammatory bowel disease: an online Australia-wide survey. J Crohns Colitis 8:296–303

    Article  PubMed  Google Scholar 

  32. Mahadev S, Young JM, Selby W, Solomon MJ (2012) Self-reported depressive symptoms and suicidal feelings in perianal Crohn’s disease. Color Dis 14:331–335

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gastroenterology Unit, Department of Biomedical and Clinical Sciences, L. Sacco University Hospital, Via G.B. Grassi 74, 20157, Milan, Italy

    Giovanni Maconi, Daniele Gridavilla, Roberta Sciurti, Federica Furfaro & Sandro Ardizzone

  2. Psychiatry Unit, Department of Biomedical and Clinical Sciences, L. Sacco University Hospital, Milan, Italy

    Caterina Viganò, Federica Re & Gabriella Ba

  3. Department of Gastroenterology, The Alfred Hospital and Monash University, Melbourne, Victoria, Australia

    Anil K. Asthana

Authors
  1. Giovanni Maconi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniele Gridavilla
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Caterina Viganò
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Roberta Sciurti
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Anil K. Asthana
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Federica Furfaro
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Federica Re
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Sandro Ardizzone
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Gabriella Ba
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giovanni Maconi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Maconi, G., Gridavilla, D., Viganò, C. et al. Perianal disease is associated with psychiatric co-morbidity in Crohn’s disease in remission. Int J Colorectal Dis 29, 1285–1290 (2014). https://doi.org/10.1007/s00384-014-1935-6

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-014-1935-6

Keywords

Search

Navigation